Stake history
0% 10% 20% 30% 40% 15.95% Prior Prior: 15.95% · prior ratio stated in S100U2AC 11.95% Jul 19 Jul 19: 11.95% · S100U2AC 10.84% Jul 31 Jul 31: 10.84% · S100U4O9 7.74% Aug 16 Aug 16: 7.74% · S100U8RP 6.26% Aug 19 Aug 19: 6.26% · S100U8X2 6.54% Aug 20 Aug 20: 6.54% · S100U93J 5.42% Aug 28 Aug 28: 5.42% · S100UABN 31.76% Aug 30 Aug 30: 31.76% · S100UAIR 30.25% Sep 2 Sep 2: 30.25% · S100UB4P 29.54% Sep 5 Sep 5: 29.54% · S100UBSR 29.59% Sep 10 Sep 10: 29.59% · S100UCKF 0% 10% 20% 30% 40% 15.95% Prior Prior: 15.95% · prior ratio stated in S100U2AC 11.95% Jul 19 Jul 19: 11.95% · S100U2AC 10.84% Jul 31 Jul 31: 10.84% · S100U4O9 7.74% Aug 16 Aug 16: 7.74% · S100U8RP 6.26% Aug 19 Aug 19: 6.26% · S100U8X2 6.54% Aug 20 Aug 20: 6.54% · S100U93J 5.42% Aug 28 Aug 28: 5.42% · S100UABN 31.76% Aug 30 Aug 30: 31.76% · S100UAIR 30.25% Sep 2 Sep 2: 30.25% · S100UB4P 29.54% Sep 5 Sep 5: 29.54% · S100UBSR 29.59% Sep 10 Sep 10: 29.59% · S100UCKF Summary
Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2024-09-10 12:07 JST concerning Modalis Therapeutics Corporation. Reported holding ratio: 29.59%, previous report: 29.54%.
Open the price chart on TradingView.
Source: EDINET S100UCKF ↗ · PDL1.0 · Not investment advice